Fewer than 20% of type 2 diabetes patients on most effective medicine for them, model shows The model was also associated with a 38% reduction in the likelihood of glycaemic failure over five years.…
SIGN rejects opioids and medicinal cannabis for chronic pain in draft guidance Draft guidance on management of chronic pain included medicinal cannabis for the first time, not recommending it on the basis of limited clinical evidence and consistent evidence of adverse effects.…
Nine in ten people would accept a pharmacogenomics test, reveals survey The majority of respondents to a survey said they would be motivated to take a pharmacogenomics test to enhance drug effectiveness and reduce the risk of adverse drug reactions.…
David Taylor (1946–2025) Lauded as an “instrumental” figure in UK pharmacy by his peers, David Taylor held a broad range of influential teaching and public health policy roles during his career.…
Royal college vote to take place in March 2025, says RPS Royal Pharmaceutical Society members will vote on proposed changes to its Royal Charter, which would lead to it becoming the Royal College of Pharmacy.…
Pharmacogenomics trial expands across England Programme co-ordinators are aiming to recruit a further 1,450 people to the second phase of the PROGRESS trial, which is the first in the UK to introduce genetic testing before prescribing in primary care.…
Manufacturers invited to apply for medicines reclassification The Department of Health and Social Care has published a list of conditions where prescription-only restrictions on medicines could be removed, including gastrointestinal, skin and women’s health, as well as heartburn, eczema and heavy periods.…
José Moss (1965–2025) A cherished member of the pharmacy community, Josephine Moss is remembered for her commitment to championing professional integrity and patient care.…
Inhaler return to pharmacies part of updated NHS ‘Green plan guidance’ The updated guidance encourages trusts and other NHS organisations to renew their sustainability plans for the next three-year cycle in order to help achieve NHS net zero carbon emissions.…
NICE approves gene-editing sickle cell therapy for NHS in England Exagamglogene autotemcel, also known as exa-cel, is now recommended for NHS use, reversing previous draft guidance.…